North Tide Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-100,000
Closed -$21M 18
2016
Q4
$21M Buy
+100,000
New +$20.7M 3.59% 10
2016
Q3
Sell
-150,000
Closed -$34.7M 21
2016
Q2
$34.7M Buy
+150,000
New +$34.6M 3.86% 12
2014
Q2
Sell
-400,000
Closed -$82.3M 28
2014
Q1
$82.3M Sell
400,000
-50,000
-11% -$9.9M 6.94% 5
2013
Q4
$75.6M Buy
450,000
+350,000
+350% +$54.7M 6.62% 5
2013
Q3
$14.4M Buy
+100,000
New +$13.3M 1.51% 19

Other funds holding AGN

North Tide Capital's AGN Position: Q1 2017 in Review

North Tide Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 100,000 shares — an estimated $21M sold.

North Tide Capital first reported a position in AGN in Q3 2013 and held it in 5 quarters. The position peaked at $82.3M in Q1 2014. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • North Tide Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • North Tide Capital sold 100,000 Allergan plc shares in Q1 2017, an estimated $21M.
  • North Tide Capital first reported a position in Allergan plc in Q3 2013 and held it in 5 quarters.
  • North Tide Capital's Allergan plc position peaked at $82.3M in Q1 2014.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on North Tide Capital's 13F filing for Q1 2017, filed 15 May 2017.